Sydney Vital Cancer Conference 2016
Why do normal cells transform into cancer cells?
The future of Cancer Control
Join us to hear about why normal cells transform into cancer cells, and how cancer treatment will change in the next 5 to 10 years.
A panel of medical specialists and patient advocates will be available to discuss how cancer research improves cancer outcomes.
You will learn more about modern medical discoveries and technology, and how their are influencing cancer control.
Professor Sean Grimmond
Director & The Bertalli Chair in Cancer Medicine
The University of Melbourne Centre for Cancer Research
Professor Grimmond is a pioneer of whole-genome and transciptome analysis of cancer patients, led Australia's International Cancer Genome Consortium efforts into pancreatic, neuroendocrine and ovarian cancer, and contributed cohort-based mutational landscape studies in melanoma and oesophageal cancer.
These studies have been used to resolve the mutagenic processes, driver mutations, molecular taxonomies, and potential vulnerabilities open to therapeutic exploitation in these cancer types.
His current research is firmly focused on real-time omic analysis of recalcitrant cancers, testing the value of personalised therapies, and further cancer genome discovery.
Prof Dale Bailey
Prof Stephen Clarke
A/Prof Thomas Eade
A/Prof Alexander Engel
Prof Anthony Gill
Prof Sean Grimmond
A/Prof Melanie Lovell